enoximone has been researched along with Pregnancy in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, CM; Ward Platt, MP | 1 |
| Hackmann, F; Hellige, G; Hoebel, D; Luers, F; Pfahlberg, A; Rizouli, V; Schiffmann, H | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Robin, NM; Wenstone, R | 1 |
1 review(s) available for enoximone and Pregnancy
| Article | Year |
|---|---|
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
3 other study(ies) available for enoximone and Pregnancy
| Article | Year |
|---|---|
Neonatal flecainide toxicity following supraventricular tachycardia treatment.
Topics: Anti-Arrhythmia Agents; Dobutamine; Enoximone; Female; Fetal Diseases; Flecainide; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Tachycardia, Supraventricular | 2003 |
Na(+)-channel modulation, a new principle of inotropic intervention: effects on hemodynamic and myocardial energetics in the immature rabbit heart.
Topics: Age Factors; Animals; Animals, Newborn; Azetidines; Cardiotonic Agents; Coronary Circulation; Cyclic AMP; Enoximone; Female; Isoproterenol; Models, Cardiovascular; Myocardial Contraction; Myocardium; Ouabain; Oxygen Consumption; Pregnancy; Rabbits; Sodium Channels | 2003 |
The use of enoximone in peripartum cardiomyopathy.
Topics: Adult; Cardiomyopathies; Cardiotonic Agents; Enoximone; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 1998 |